Objective
=========

Our objective was to characterize the molecules responsible for crosstalk between synovial fibroblasts (SFibs) and T lymphocytes (TLs) in RA and test the effect of methotrexate (MTX).

Methods
=======

SFibs were obtained from RA patients. TLs were isolated from peripheral blood of healthy controls and RA patients, and from RA synovial fluid by Ficoll--Hypaque gradient and magnetic depletion of non-T cells; purity was 99%. Cocultures were established in six-well plates; adhesion molecules and surface and intracellular cytokines were determined by flow cytometry.

Results
=======

Synovial fluid TLs (SFTLs) from RA patients (*n* = 10) and peripheral blood TLs (PBTLs) from untreated recent-onset RA (*n* = 10) induced an up-regulation of intercellular adhesion molecule (ICAM)-1, intracellular IL-8, IL-15 and surface IL-15 in SFibs. SFTLs and PBTLs showed an up-regulation of IFN-γ, IL-17, CD25 and CD69 when cocultured with SFibs. Freshly isolated PBTLs from healthy controls (*n* = 10) did not induce SFib cytokine production. Pretreatment of SFs with MTX (0.1--1 μM) prevented the TL-stimulated increase of IL-8 and IL-15. Pretreatment of TLs with MTX (0.1--1 μM) prevented the SFib-induced up-regulation of IFN-γ, IL-17, CD25 and CD69. Blocking MoAbs to IL-15, but not an isotype-control antibody, prevented the increased TL secretion of IFN-γ and IL-17 induced by SFibs. Blocking MoAbs to IL-17 significantly decreased the TL-induced up-regulation of IL-8 and IL-15 in SFibs. Cocultures of TLs and SFibs using 0.4μM plate inserts did not induce a significant up-regulation of adhesion molecules or cytokines. Paraformaldehide-fixed TLs did up-regulate IL-8 and IL-15 in SFibs. This suggests that direct cell contact is an important contributor to the observed effects.

Conclusion
==========

SFib production of IL-8 and IL-15 may contribute to the influx and proliferation of TL in the RA joint. In turn, TL cytokines IFN-γ and IL-17 stimulate the production of IL-8 and IL-15 by Sfibs, thereby creating a feedback loop that leads to persistent synovial inflammation. MTX seems to disrupt this loop, acting at both the SFib and TL level.
